| 6/11/2010 | BKCVHY | Moody's: Inverness unchanged
|
| 9/22/2009 | BKCVHY | S&P assigns Inverness notes B-
|
| 9/22/2009 | BKCVHY | Moody's rates Inverness Medical notes B2
|
| 8/5/2009 | BKCVHY | S&P rates Inverness Medical debt B-
|
| 5/4/2009 | BKCVHY | Moody's gives Inverness notes B3
|
| 5/4/2009 | BKCVHY | S&P gives Inverness notes B-
|
| 4/13/2009 | CVHY | Inverness Medical Innovations files automatic shelf registration
|
| 4/6/2009 | BKCVHY | S&P: Inverness view positive
|
| 3/19/2009 | BKCVHY | Moody's lifts Inverness
|
| 3/19/2009 | CV | Inverness to pay April dividends on convertible preferreds in kind
|
| 6/19/2008 | BKCVHY | Moody's confirms Inverness
|
| 5/19/2008 | BKCVHY | S&P gives Inverness convertible preferreds CCC+
|
| 5/15/2008 | CV | Inverness sweetens conversion price of 3% convertibles due 2016 to $43.98
|
| 5/9/2008 | CV | Inverness Medical convertible preferred stock offers value relative to common: Lehman analysts
|
| 5/9/2008 | CV | Inverness issues about $720 million perpetual convertible preferreds for Matria merger
|
| 1/28/2008 | BKCVHY | S&P affirms Inverness
|
| 1/28/2008 | BKCVHY | Moody's may cut Inverness
|
| 6/19/2007 | BKCVHY | S&P affirms Inverness Medical, gives loans BB, B-
|
| 6/18/2007 | BKCVHY | Moody's rates Inverness loans B1, Caa1
|
| 5/21/2007 | BKCVHY | S&P keeps Inverness on watch, rates convertibles B-
|
| 5/15/2007 | CVPP | New Issue: Inverness sells upsized $150 million of 10-year convertibles to yield 3%, up 30%
|
| 5/10/2007 | CV | Inverness sells $132.5 million 10-year convertibles to yield 3%, up 30%
|
| 5/10/2007 | CV | Market Commentary: Amgen falls under drug panel scrutiny; Alesco, Chesapeake gain early, end flat; CACI, L-1 quiet in gray
|
| 5/9/2007 | CV | Inverness prices $132.5 million convertibles at 3%, up 30%
|
| 11/22/2006 | CVHY | Inverness Medical Innovations files stock, warrant shelf
|
